Tema Heart & Health ETF (HRTS)

HRTS Holdings Information

HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 7.85%, Abbott Laboratories at 4.71%, UnitedHealth Group at 4.66%, AstraZeneca at 4.53%, and Roche Holding AG at 4.27%.

• Total Holdings: 46
• Top 10 Percentage: 43.80%
• Asset Class: Equity
• ETF Category: Health
• Assets: 49.05M
• PE Ratio: 19.94

Top 25 Holdings

As of Aug 19, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	7.85%	5,468
2	ABT	Abbott Laboratories	4.71%	17,577
3	UNH	UnitedHealth Group Incorporated	4.66%	7,501
4	LON: AZN	AstraZeneca PLC	4.53%	13,951
5	RHHBY	Roche Holding AG	4.27%	51,890
6	BSX	Boston Scientific Corporation	3.84%	18,129
7	GILD	Gilead Sciences, Inc.	3.56%	14,795
8	ABBV	AbbVie Inc.	3.53%	8,383
9	TMO	Thermo Fisher Scientific Inc.	3.43%	3,369
10	CPH: NOVO.B	Novo Nordisk A/S	3.42%	30,869
11	SWX: NOVN	Novartis AG	3.30%	12,936
12	MDT	Medtronic plc	2.98%	16,259
13	BBIO	BridgeBio Pharma, Inc.	2.97%	29,790
14	VRTX	Vertex Pharmaceuticals Incorporated	2.59%	3,249
15	MRK	Merck & Co., Inc.	2.57%	14,811
16	CRNX	Crinetics Pharmaceuticals, Inc.	2.55%	42,505
17	AMGN	Amgen Inc.	2.55%	4,230
18	ALNY	Alnylam Pharmaceuticals, Inc.	2.51%	2,687
19	DHR	Danaher Corporation	2.43%	5,616
20	REGN	Regeneron Pharmaceuticals, Inc.	2.15%	1,838
21	EW	Edwards Lifesciences Corporation	2.13%	13,227
22	BMY	Bristol-Myers Squibb Company	2.08%	21,064
23	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	1.98%	21,921
24	DXCM	DexCom, Inc.	1.97%	11,946
25	MCK	McKesson Corporation	1.82%	1,315

As of Aug 19, 2025

Showing 25 of 46

Subscribe to see the full list